Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.71

-0.8%

11:11 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harold Engstrom who wrote (3755)	5/11/2001 10:13:24 AM
From: Biomaven	of 52153

This graph of NCE approval times is interesting: fda.gov I hadn't realized just how many drug approvals take more than 12 months. I don't fully understand the graph, though - if it really was a graph of NDA's received and approved in 36 months shouldn't all the graphs end at 100% because the graph goes out to 36 months? I would assume the missing numbers are NDA's that were approved in longer than 36 months rather than NDA's that were rejected (I think the latter would have been a bigger number). This table of Subpart H approvals (surrogate endpoint) is also interesting: fda.gov Peter BTW, I commented briefly on the RSTA deal over on the munch thread: Message 15786731

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next